| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.26▲ | 1.27▲ | 1.27▲ | 1.32▼ | 1.34▼ |
| MA10 | 1.27▲ | 1.27▲ | 1.31▼ | 1.35▼ | 1.35▼ |
| MA20 | 1.27▲ | 1.31▼ | 1.32▼ | 1.37▼ | 1.20▲ |
| MA50 | 1.28▼ | 1.35▼ | 1.46▼ | 1.35▼ | 1.43▼ |
| MA100 | 1.31▼ | 1.44▼ | 1.39▼ | 1.17▲ | 1.52▼ |
| MA200 | 1.33▼ | 1.42▼ | 1.36▼ | 1.26▲ | 2.09▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | 0.000▼ | 0.000▼ | -0.014▼ | 0.022▲ |
| RSI | 50.428▲ | 42.603▼ | 39.389▼ | 47.203▼ | 49.787▼ |
| STOCH | 56.349 | 24.759 | 17.046▼ | 27.457 | 35.259 |
| WILL %R | -14.286▲ | -73.913 | -78.571▼ | -85.256▼ | -59.375 |
| CCI | 35.616 | -56.203 | -105.834▼ | -59.755 | -34.450 |
|
Sunday, November 16, 2025 12:32 PM
In a report released yesterday, Joseph Schwartz from Leerink Partners reiterated a Buy rating on InflaRx, with a price target of $2.00. The company’s shares closed yesterday at $1.51. Take advantage ...
|
|
Monday, November 10, 2025 04:44 AM
Phase 2a data support oral C5aR inhibitor INF904 as a potentially transformational and best-in-class immunomodulatory agent, indicating strong potential for efficacy and no safety signals of concernIn ...
|
|
Monday, November 10, 2025 03:45 AM
Investing.com -- InflaRx (NASDAQ:IFRX) stock surged 60% after the biopharmaceutical company reported positive Phase 2a data for its oral C5aR inhibitor INF904 in treating Hidradenitis Suppurative (HS) ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 18/11/25 | 1.27 | 1.31 | 1.245 | 1.275 | 467,870 |
| 17/11/25 | 1.36 | 1.38 | 1.24 | 1.24 | 1,673,974 |
| 14/11/25 | 1.32 | 1.413 | 1.28 | 1.35 | 1,490,800 |
| 13/11/25 | 1.42 | 1.52 | 1.25 | 1.27 | 5,168,466 |
| 12/11/25 | 1.71 | 1.85 | 1.43 | 1.46 | 7,007,812 |
| 11/11/25 | 1.66 | 1.94 | 1.54 | 1.65 | 17,563,096 |
| 10/11/25 | 1.77 | 1.84 | 1.40 | 1.58 | 83,568,017 |
| 07/11/25 | 1.19 | 1.25 | 1.16 | 1.23 | 25,890,685 |
| 06/11/25 | 1.25 | 1.25 | 1.18 | 1.20 | 480,978 |
| 05/11/25 | 1.28 | 1.35 | 1.23 | 1.24 | 496,695 |
|
|
||||
|
|
||||
|
|